You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 6, December 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antiglaucoma Drug Effects on Corneal Epithelium

A Comparative Study in Tissue Culture

Lubomir Krejci, MD; Raymond Harrison, MD

Arch Ophthalmol. 1970;84(6):766-769.


Abstract

Rabbit and human corneal epithelium was studied in tissue cultures for the effects of a variety of topically administered antiglaucoma drugs at 0.001% of their commonly prescribed concentrations. The evolution of degenerative changes was observed using different therapeutic agents and controls. In the selected concentrations tested, the strongest cytotoxic effects were produced by neostigmine bromide (Prostigmine) and carbachol (Isopto Carbachol); epinephrine and echothiophate (Phospholine) iodide were slightly less damaging. Intermediate degrees of toxicity were shown by guanethidine sulfate and a preparation of pilocarpine hydrochloride with epinephrine (P1E1) Demecarium bromide (Humorsol) and pilocarpine were least toxic. Preparations containing epinephrine produced pigment deposition. Methylcellulose (Methulose), edetate disodium, and commonly used preservatives showed no adverse effects in comparison with untreated control cultures. The results may help in choosing the least toxic drugs for topical application to glaucomatous eyes complicated by abnormal corneal epithelium.



Author Affiliations

New York

From the Eye Bank for Sight Restoration, Inc., and the Glaucoma Service, Manhattan Eye, Ear, and Throat Hospital, New York. Dr. Krejci was a visiting research fellow from Prague. His present address is Prague 3-Zizkov, Jeseniova 186, Czechoslovakia.


Footnotes

Submitted for publication June 4, 1970.

Reprint requests to 140 E 54th St, New York 10022 (Dr. Harrison).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glaucoma
Armaly
Arch Ophthalmol 1972;88:439-460.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.